v3.26.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (10,473,672) $ (8,399,166)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Stock-based compensation 1,879,890 1,107,520
Depreciation and amortization 511,457 174,590
Amortization of Right-of-Use Asset 31,439 178,623
Unrealized loss on change in fair value of derivatives 320,404 290,616
Loss on disposal of fixed assets 149,125
Loss on impairment of licensing agreement 1,000,000
Loss on write down of inventory 239,935
Amortization of debt discount 936,552 106,513
Common stock issued for services 192,676 574,291
Stock issued in lieu of compensation, net of cancelled shares 359,500
Common stock issued for stock option buyout program 72,808
Gain on extinguishment of debt (66,075)
Loss on sale of lease vehicles 1,018
Changes in Operating Assets and Liabilities    
(Increase) decrease in prepaid expenses and other assets 177,871 97,710
(Increase) decrease in accounts receivable (45,144) (41,904)
(Increase) decrease in inventory (454,797) 66,572
(Decrease) increase in accounts payable and accrued expenses (649,027) 271,450
Lease liabilities (31,439) (179,641)
Accrued interest in notes payable 107,444 63,622
Net Cash (Used In) Operating Activities (6,107,286) (5,321,953)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of property and equipment (7,734) (63,434)
Payments received on disposal of equipment 4,874
Payments made on licensing agreement (500,000)
Security deposits 14,660
Net Cash Provided by (Used In) Investing Activities 11,800 (563,434)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the sale of common stock and warrants 675,000 2,050,100
Proceeds from exercise of warrants 1,818,000
Proceeds from preferred stock subscription receivable 4,400,000
Proceeds from the issuance of convertible debentures 160,000 1,865,000
Proceeds from the exercise of warrants 851,750
Proceeds from the issuance of notes payable 332,000 300,000
Repayments of notes payable (350,171) (7,427)
Net Cash Provided by Financing Activities 6,068,579 6,025,673
Net increase (decrease) in Cash (26,907) 140,286
Cash at Beginning of the Year 227,689 87,403
Cash at End of the Year 200,782 227,689
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest 21,801 8,360
Income Taxes
SUPPLEMENTAL DISCLOSURE ON NON-CASH FINANCING AND INVESTING ACTIVITIES    
Derecognition and decrease of operating lease right-of-use asset and lease liability (890,979)
Common stock issued on conversion of convertible notes and accrued interest 2,018,154 301,558
(Decrease) increase to operating lease right of use asset and operating lease liabilities (53,168)
Vesting of restricted stock units 175 428
Stock issued for conversion of accounts payable 6,000
Dividends declared on Series B preferred stock 403,603
Stock issued for conversion of accrued dividends 278,603
Stock issued for licensing agreement 800,000 1,000,000
Stock issued for investment 150,000
(Decrease) increase to accrued expenses for licensing agreement (125,000) 500,000
Warrants issued as debt discount 98,684
Derivative liabilities as debt discount 341,576
Stock to be issued for common stock subscription receivable 600,000
Preferred stock subscription $ 4,400,000